Literature DB >> 23935177

Neuropathologic basis of white matter hyperintensity accumulation with advanced age.

Deniz Erten-Lyons1, Randall Woltjer, Jeffrey Kaye, Nora Mattek, Hiroko H Dodge, Sarah Green, Huong Tran, Diane B Howieson, Katherine Wild, Lisa C Silbert.   

Abstract

OBJECTIVE: To determine which vascular pathology measure most strongly correlates with white matter hyperintensity (WMH) accumulation over time, and whether Alzheimer disease (AD) neuropathology correlates with WMH accumulation.
METHODS: Sixty-six older persons longitudinally followed as part of an aging study were included for having an autopsy and >1 MRI scan, with last MRI scan within 36 months of death. Mixed-effects models were used to examine the associations between longitudinal WMH accumulation and the following neuropathologic measures: myelin pallor, arteriolosclerosis, microvascular disease, microinfarcts, lacunar infarcts, large-vessel infarcts, atherosclerosis, neurofibrillary tangle rating, and neuritic plaque score. Each measure was included one at a time in the model, adjusted for duration of follow-up and age at death. A final model included measures showing an association with p < 0.1.
RESULTS: Mean age at death was 94.5 years (5.5 SD). In the final mixed-effects models, arteriolosclerosis, myelin pallor, and Braak score remained significantly associated with increased WMH accumulation over time. In post hoc analysis, we found that those with Braak score 5 or 6 were more likely to also have high atherosclerosis present compared with those with Braak score 1 or 2 (p = 0.003).
CONCLUSION: Accumulating white matter changes in advanced age are likely driven by small-vessel ischemic disease. Additionally, these results suggest a link between AD pathology and white matter integrity disruption. This may be due to wallerian degeneration secondary to neurodegenerative changes. Alternatively, a shared mechanism, for example ischemia, may lead to both vascular brain injury and neurodegenerative changes of AD. The observed correlation between atherosclerosis and AD pathology supports the latter.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23935177      PMCID: PMC3888199          DOI: 10.1212/WNL.0b013e3182a43e45

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

Authors:  M S Green; J A Kaye; M J Ball
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

2.  White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury.

Authors:  Malee S Fernando; Julie E Simpson; Fiona Matthews; Carol Brayne; Claire E Lewis; Robert Barber; Raj N Kalaria; Gill Forster; Filomena Esteves; Stephen B Wharton; Pamela J Shaw; John T O'Brien; Paul G Ince
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

3.  Brain volume preserved in healthy elderly through the eleventh decade.

Authors:  E A Mueller; M M Moore; D C Kerr; G Sexton; R M Camicioli; D B Howieson; J F Quinn; J A Kaye
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

4.  The Mini-Mental State Examination.

Authors:  M F Folstein; L N Robins; J E Helzer
Journal:  Arch Gen Psychiatry       Date:  1983-07

Review 5.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.

Authors:  Alida A Gouw; Alexandra Seewann; Wiesje M van der Flier; Frederik Barkhof; Annemieke M Rozemuller; Philip Scheltens; Jeroen J G Geurts
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-09       Impact factor: 10.154

6.  Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.

Authors:  W T Longstreth; Alice M Arnold; Norman J Beauchamp; Teri A Manolio; David Lefkowitz; Charles Jungreis; Calvin H Hirsch; Daniel H O'Leary; Curt D Furberg
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

Review 7.  Alzheimer disease as a vascular disorder: nosological evidence.

Authors:  J C de la Torre
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

8.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging.

Authors:  M Bozzali; A Falini; M Franceschi; M Cercignani; M Zuffi; G Scotti; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

9.  Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.

Authors:  Lawrence S Honig; Walter Kukull; Richard Mayeux
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

10.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Authors:  Mark Yarchoan; Sharon X Xie; Mitchel A Kling; Jon B Toledo; David A Wolk; Edward B Lee; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Steven E Arnold
Journal:  Brain       Date:  2012-11-30       Impact factor: 13.501

View more
  93 in total

1.  Differential aging of cerebral white matter in middle-aged and older adults: A seven-year follow-up.

Authors:  Andrew R Bender; Manuel C Völkle; Naftali Raz
Journal:  Neuroimage       Date:  2015-10-19       Impact factor: 6.556

2.  Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

Authors:  Adam M Brickman; Laura B Zahodne; Vanessa A Guzman; Atul Narkhede; Irene B Meier; Erica Y Griffith; Frank A Provenzano; Nicole Schupf; Jennifer J Manly; Yaakov Stern; José A Luchsinger; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2014-07-21       Impact factor: 4.673

Review 3.  Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.

Authors:  Adam M Brickman
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

4.  Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients.

Authors:  Dejan Jakimovski; Ralph Hb Benedict; Karen Marr; Sirin Gandhi; Niels Bergsland; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  Mult Scler       Date:  2019-01-09       Impact factor: 6.312

5.  White matter hyperintensities and imaging patterns of brain ageing in the general population.

Authors:  Mohamad Habes; Guray Erus; Jon B Toledo; Tianhao Zhang; Nick Bryan; Lenore J Launer; Yves Rosseel; Deborah Janowitz; Jimit Doshi; Sandra Van der Auwera; Bettina von Sarnowski; Katrin Hegenscheid; Norbert Hosten; Georg Homuth; Henry Völzke; Ulf Schminke; Wolfgang Hoffmann; Hans J Grabe; Christos Davatzikos
Journal:  Brain       Date:  2016-02-24       Impact factor: 13.501

6.  Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.

Authors:  David A Wolk; Carl Sadowsky; Beth Safirstein; Juha O Rinne; Ranjan Duara; Richard Perry; Marc Agronin; Jose Gamez; Jiong Shi; Adrian Ivanoiu; Lennart Minthon; Zuzana Walker; Steen Hasselbalch; Clive Holmes; Marwan Sabbagh; Marilyn Albert; Adam Fleisher; Paul Loughlin; Eric Triau; Kirk Frey; Peter Høgh; Andrea Bozoki; Roger Bullock; Eric Salmon; Gillian Farrar; Christopher J Buckley; Michelle Zanette; Paul F Sherwin; Andrea Cherubini; Fraser Inglis
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

7.  A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting.

Authors:  Andrea Vergallo; Cecilia Carlesi; Cristina Pagni; Filippo Sean Giorgi; Filippo Baldacci; Lucia Petrozzi; Roberto Ceravolo; Gloria Tognoni; Gabriele Siciliano; Ubaldo Bonuccelli
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

Review 8.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

9.  Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.

Authors:  Mina Park; Yeonsil Moon; Seol-Heui Han; Ho Kyun Kim; Won-Jin Moon
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

10.  An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Authors:  Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  Alzheimers Dement       Date:  2016-08-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.